181 related articles for article (PubMed ID: 37701690)
61. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer.
Koerner AS; Moy RH; Ryeom SW; Yoon SS
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627142
[TBL] [Abstract][Full Text] [Related]
62. Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Pecorelli N; Licinio AW; Guarneri G; Aleotti F; Crippa S; Reni M; Falconi M; Balzano G
Front Oncol; 2021; 11():812102. PubMed ID: 35083158
[TBL] [Abstract][Full Text] [Related]
63. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
64. Neoadjuvant chemotherapy-induced severe neutropenia is associated with histopathological response and survival in locally advanced gastric cancer.
Wu C; Wang T; Zhou H; Zhang X; Guo C; Chen Y; Zhao D
Transl Cancer Res; 2020 Jan; 9(1):280-293. PubMed ID: 35117182
[TBL] [Abstract][Full Text] [Related]
65. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
66. Upfront surgery vs. neoadjuvant therapy for resectable pancreatic cancer: a narrative review of available evidence.
Ratnayake CBB; Roberts KJ; Pandanaboyana S
Chin Clin Oncol; 2022 Feb; 11(1):2. PubMed ID: 35184565
[TBL] [Abstract][Full Text] [Related]
67. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
68. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
69. Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis.
Wang Z; Dong L; Shi W; Gao L; Jiang X; Xue S; Chang P
Adv Clin Exp Med; 2023 Dec; ():. PubMed ID: 38085005
[TBL] [Abstract][Full Text] [Related]
70. Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy.
Li CC; Yeh YS; Chen YC; Su WC; Chang TK; Tsai HL; Huang CW; Ma CJ; Yin TC; Chen PJ; Wang JY
J Oncol; 2022; 2022():3719241. PubMed ID: 35345514
[TBL] [Abstract][Full Text] [Related]
71. Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study.
Sun Y; Fan Y; Ye Z; Dong J; Zhang L; Peng Y
Ir J Med Sci; 2023 Jun; 192(3):1033-1040. PubMed ID: 35819743
[TBL] [Abstract][Full Text] [Related]
72. Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis.
Toyoda J; Sahara K; Takahashi T; Miyake K; Yabushita Y; Sawada Y; Homma Y; Matsuyama R; Endo I; Pawlik TM
J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048737
[No Abstract] [Full Text] [Related]
73. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.
Zhu Y; Chen J; Sun X; Lou Y; Fang M; Zhou F; Zhang L; Xin Y
Front Oncol; 2023; 13():1177557. PubMed ID: 37228495
[TBL] [Abstract][Full Text] [Related]
74. Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study.
Wang C; Wang Z; Zhao Y; Wang F
J Gastric Cancer; 2023 Apr; 23(2):328-339. PubMed ID: 37129156
[TBL] [Abstract][Full Text] [Related]
75. The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.
Fuentes E; Ahmad R; Hong TS; Clark JW; Kwak EL; Rattner DW; Mullen JT
J Surg Oncol; 2016 Apr; 113(5):560-4. PubMed ID: 26792144
[TBL] [Abstract][Full Text] [Related]
76. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
[No Abstract] [Full Text] [Related]
77. [Historical evolution and research progress of perioperative therapy of locally advanced gastric cancer].
Chen J; Ye Q; Huang F
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):196-200. PubMed ID: 30799543
[TBL] [Abstract][Full Text] [Related]
78. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
79. Neoadjuvant chemotherapy followed by surgery versus upfront surgery in non-metastatic non-small cell lung cancer: systematic review and meta-analysis of randomized controlled trials.
Zhang XN; Huang L
Oncotarget; 2017 Oct; 8(52):90327-90337. PubMed ID: 29163832
[TBL] [Abstract][Full Text] [Related]
80. A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy.
Bartels HC; Rogers AC; McSharry V; McVey R; Walsh T; O'Brien D; Boyd WD; Brennan DJ
Gynecol Oncol; 2019 Sep; 154(3):622-630. PubMed ID: 31349996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
